The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

abacusbioscience.com

Stage

Spinoff / Spinout | Alive

About Abacus Bioscience

Abacus Bioscience specializes in developing novel immunotherapeutic treatments for managing cancer and antiviral diseases using a CD180 backbone. It is based in Seattle, Washington.

Abacus Bioscience Headquarter Location

4545 Roosevelt Way Northeast Suite 400

Seattle, Washington, 98105,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Abacus Bioscience Patents

Abacus Bioscience has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/22/2016

5/10/2022

Monoclonal antibodies, Vaccines, Clusters of differentiation, Molecular biology, Immunology

Grant

Application Date

11/22/2016

Grant Date

5/10/2022

Title

Related Topics

Monoclonal antibodies, Vaccines, Clusters of differentiation, Molecular biology, Immunology

Status

Grant

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.